Short description
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Description
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
Last funding
No Way
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
South San Francisco, California, United States, North America
Founded on
January 1, 2008
Exited on
October 8, 2015
Went public on
October 8, 2015
Stock symbol
CTMX
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccessforu, Cannot Access, Noway Youcantaccess, Uh Ohhhh, Absolutely Noaccess, No Way, Noaccess, Cannot Access, Cannot Access, Noaccess, Noaccess, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Fred Gluck, Nancy E. Stagliano, Patrick Daugherty